{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:42:25Z","timestamp":1776973345648,"version":"3.51.4"},"reference-count":45,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["GN2617"],"award-info":[{"award-number":["GN2617"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Treatments for amblyopia, the most common vision deficit in children, often have suboptimal results. Occlusion\/atropine blurring are fraught with poor adherence, regression and recurrence. These interventions target only the amblyopic eye, failing to address imbalances of cortical input from the two eyes (\u2018suppression\u2019). Dichoptic treatments manipulate binocular visual experience to rebalance input. Poor adherence in early trials of dichoptic therapies inspired our development of balanced binocular viewing (BBV), using movies as child-friendly viewable content. Small observational studies indicate good adherence and efficacy. A feasibility trial is needed to further test safety and gather information to design a full trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods\/analysis<\/jats:title><jats:p>We will carry out an observer-masked parallel-group phase 2a feasibility randomised controlled trial at two sites, randomising 44 children aged 3\u20138 years with unilateral amblyopia to either BBV or standard occlusion\/atropine blurring, with 1:1 allocation ratio. We will assess visual function at baseline, 8 and 16 weeks. The primary outcome is intervention safety at 16 weeks, measured as change in interocular suppression, considered to precede the onset of potential diplopia. Secondary outcomes include safety at other time points, eligibility, recruitment\/retention rates, adherence, clinical outcomes. We will summarise baseline characteristics for each group and assess the treatment effect using analysis of covariance. We will compare continuous clinical secondary endpoints between arms using linear mixed effect models, and report feasibility endpoints using descriptive statistics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics\/dissemination<\/jats:title><jats:p>This trial has been approved by the London-Brighton &amp; Sussex Research Ethics Committee (18\/LO\/1204), National Health Service Health Research Authority and Medicines and Healthcare products Regulatory Agency. A lay advisory group will be involved with advising on and disseminating the results to non-professional audiences, including on websites of funder\/participating institutions and inputting on healthcare professional audience children would like us to reach. Reporting to clinicians and scientists will be via internal and external meetings\/conferences and peer-reviewed journals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03754153\">NCT03754153<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2021-051423","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:07:01Z","timestamp":1653466021000},"page":"e051423","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Phase 2a randomised controlled feasibility trial of a new \u2018balanced binocular viewing\u2019 treatment for unilateral amblyopia in children age 3\u20138 years: trial protocol"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03754153","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7402-4350","authenticated-orcid":false,"given":"Annegret Hella","family":"Dahlmann-Noor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-0818","authenticated-orcid":false,"given":"John A","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-372X","authenticated-orcid":false,"given":"Andrew","family":"Skilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0161-443X","authenticated-orcid":false,"given":"Daniel","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan","family":"Ludden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakim-Moulay","family":"Dehbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"2022063010172266000_12.5.e051423.1","doi-asserted-by":"crossref","DOI":"10.3310\/hta12250","article-title":"The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation","volume":"12","author":"Carlton","year":"2008","journal-title":"Health Technol Assess"},{"key":"2022063010172266000_12.5.e051423.2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005020.pub3","article-title":"Vision screening for amblyopia in childhood","author":"Powell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2022063010172266000_12.5.e051423.3","doi-asserted-by":"publisher","DOI":"10.1167\/3.12.5"},{"key":"2022063010172266000_12.5.e051423.4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10313"},{"key":"2022063010172266000_12.5.e051423.5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0869"},{"key":"2022063010172266000_12.5.e051423.6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4434"},{"key":"2022063010172266000_12.5.e051423.7","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7314"},{"key":"2022063010172266000_12.5.e051423.8","doi-asserted-by":"publisher","DOI":"10.3109\/09273972.2011.600423"},{"key":"2022063010172266000_12.5.e051423.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09782-9"},{"key":"2022063010172266000_12.5.e051423.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00254-9"},{"key":"2022063010172266000_12.5.e051423.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01286-1"},{"key":"2022063010172266000_12.5.e051423.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.154674"},{"key":"2022063010172266000_12.5.e051423.13","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0357"},{"key":"2022063010172266000_12.5.e051423.14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11861"},{"key":"2022063010172266000_12.5.e051423.15","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.54.1.41"},{"key":"2022063010172266000_12.5.e051423.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-8531(04)00161-2"},{"key":"2022063010172266000_12.5.e051423.17","article-title":"Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years","volume":"2015","author":"Tailor","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2022063010172266000_12.5.e051423.18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jamaophthalmol.2016.4262","article-title":"Effect of a binocular iPad game vs part-time patching in children aged 5 to 12 years with amblyopia: a randomized clinical trial","volume":"134","author":"Holmes","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2022063010172266000_12.5.e051423.19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2017.11.017","article-title":"A randomized trial of a binocular iPad game versus part-time patching in children aged 13 to 16 years with amblyopia","volume":"186","author":"Manh","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2022063010172266000_12.5.e051423.20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamaophthalmol.2017.6090","article-title":"Effectiveness of a binocular video game vs placebo video game for improving visual functions in older children, teenagers, and adults with amblyopia: a randomized clinical trial","volume":"136","author":"Gao","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"2022063010172266000_12.5.e051423.21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jamaophthalmol.2016.3657","article-title":"Binocular treatment of amblyopia in children: teething problems on the path to clinical practice","volume":"134","author":"Dahlmann-Noor","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2022063010172266000_12.5.e051423.22","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jamaophthalmol.2016.4224","article-title":"Binocular iPad game vs patching for treatment of amblyopia in children: a randomized clinical trial","volume":"134","author":"Kelly","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2022063010172266000_12.5.e051423.23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ophtha.2018.10.032","article-title":"A randomized trial of binocular dig rush game treatment for amblyopia in children aged 7 to 12 years","volume":"126","author":"Holmes","year":"2019","journal-title":"Ophthalmology"},{"key":"2022063010172266000_12.5.e051423.24","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1167\/iovs.16-20913","article-title":"Binocular therapy for childhood amblyopia improves vision without breaking interocular suppression","volume":"58","author":"Bossi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022063010172266000_12.5.e051423.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(13)32170-8"},{"key":"2022063010172266000_12.5.e051423.26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/09273972.2016.1170048","article-title":"Assessment of the density of suppression to identify risk of intractable diplopia in the United Kingdom","volume":"24","author":"Newsham","year":"2016","journal-title":"Strabismus"},{"key":"2022063010172266000_12.5.e051423.27","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310454"},{"key":"2022063010172266000_12.5.e051423.28","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.11.1498"},{"key":"2022063010172266000_12.5.e051423.29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/09273972.2016.1170047","article-title":"Dynamics of interocular suppression in amblyopic children during electronically monitored occlusion therapy: first insight","volume":"24","author":"Kehrein","year":"2016","journal-title":"Strabismus"},{"key":"2022063010172266000_12.5.e051423.30","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15611"},{"key":"2022063010172266000_12.5.e051423.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100156","article-title":"Assessing binocular interaction in amblyopia and its clinical feasibility","volume":"9","author":"Kwon","year":"2014","journal-title":"PLoS One"},{"key":"2022063010172266000_12.5.e051423.32","doi-asserted-by":"publisher","DOI":"10.1038\/srep17181"},{"key":"2022063010172266000_12.5.e051423.33","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.00469","article-title":"Can psychophysics be fun? exploring the feasibility of a Gamified contrast sensitivity function measure in Amblyopic children aged 4-9 years","volume":"7","author":"Elfadaly","year":"2020","journal-title":"Front Med"},{"key":"2022063010172266000_12.5.e051423.34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.visres.2018.09.006","article-title":"A comparison of tests for quantifying sensory eye dominance","volume":"153","author":"Bossi","year":"2018","journal-title":"Vision Res"},{"key":"2022063010172266000_12.5.e051423.35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40814-015-0018-y","article-title":"Prescribed computer games in addition to occlusion versus standard occlusion treatment for childhood amblyopia: a pilot randomised controlled trial","volume":"1","author":"Tailor","year":"2015","journal-title":"Pilot Feasibility Stud"},{"key":"2022063010172266000_12.5.e051423.36","doi-asserted-by":"publisher","DOI":"10.2165\/11599120-000000000-00000"},{"key":"2022063010172266000_12.5.e051423.37","doi-asserted-by":"crossref","unstructured":"Staniszewska S , Brett J , Simera I . GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 2017;358:3453.","DOI":"10.1136\/bmj.j3453"},{"key":"2022063010172266000_12.5.e051423.38","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.5.603"},{"key":"2022063010172266000_12.5.e051423.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.08.001"},{"key":"2022063010172266000_12.5.e051423.40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09273972.2014.1002621","article-title":"A pilot study examining density of suppression measurement in strabismus","volume":"23","author":"Piano","year":"2015","journal-title":"Strabismus"},{"key":"2022063010172266000_12.5.e051423.41","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.9.1345"},{"key":"2022063010172266000_12.5.e051423.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2008.07.007"},{"key":"2022063010172266000_12.5.e051423.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.012"},{"key":"2022063010172266000_12.5.e051423.44","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16583"},{"key":"2022063010172266000_12.5.e051423.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-051423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:42:49Z","timestamp":1656610969000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-051423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,24]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/bmjopen-2021-051423"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-051423","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}